Citigroup comments on Human Genome Sciences Inc (Nasdaq: HGSI), saying concerns about a potential delay to Albuferon Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE